CSPC Pharmaceutical Group Statistics
Total Valuation
CSPCY has a market cap or net worth of 8.36 billion. The enterprise value is 7.40 billion.
| Market Cap | 8.36B |
| Enterprise Value | 7.40B |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.14% |
| Shares Change (QoQ) | -1.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 14.10 and the forward PE ratio is 12.10.
| PE Ratio | 14.10 |
| Forward PE | 12.10 |
| PS Ratio | 2.10 |
| PB Ratio | 1.80 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | 24.22 |
| P/OCF Ratio | 13.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.32, with an EV/FCF ratio of 21.44.
| EV / Earnings | 12.48 |
| EV / Sales | 1.87 |
| EV / EBITDA | 8.32 |
| EV / EBIT | 10.29 |
| EV / FCF | 21.44 |
Financial Position
The company has a current ratio of 2.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.27 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | 0.20 |
| Interest Coverage | 122.87 |
Financial Efficiency
Return on equity (ROE) is 12.60% and return on invested capital (ROIC) is 9.57%.
| Return on Equity (ROE) | 12.60% |
| Return on Assets (ROA) | 7.40% |
| Return on Invested Capital (ROIC) | 9.57% |
| Return on Capital Employed (ROCE) | 15.44% |
| Revenue Per Employee | 185,718 |
| Profits Per Employee | 27,708 |
| Employee Count | 21,400 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 2.78 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.25% in the last 52 weeks. The beta is 0.72, so CSPCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -19.25% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 2.64 |
| Relative Strength Index (RSI) | 54.15 |
| Average Volume (20 Days) | 2,901 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPCY had revenue of 3.97 billion and earned 592.95 million in profits. Earnings per share was 0.05.
| Revenue | 3.97B |
| Gross Profit | 2.78B |
| Operating Income | 735.18M |
| Pretax Income | 764.30M |
| Net Income | 592.95M |
| EBITDA | 883.83M |
| EBIT | 735.18M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.25 billion in cash and 69.51 million in debt, giving a net cash position of 1.18 billion.
| Cash & Cash Equivalents | 1.25B |
| Total Debt | 69.51M |
| Net Cash | 1.18B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.64B |
| Book Value Per Share | 0.38 |
| Working Capital | 1.68B |
Cash Flow
In the last 12 months, operating cash flow was 621.26 million and capital expenditures -276.09 million, giving a free cash flow of 345.17 million.
| Operating Cash Flow | 621.26M |
| Capital Expenditures | -276.09M |
| Free Cash Flow | 345.17M |
| FCF Per Share | n/a |
Margins
Gross margin is 69.97%, with operating and profit margins of 18.50% and 14.92%.
| Gross Margin | 69.97% |
| Operating Margin | 18.50% |
| Pretax Margin | 19.23% |
| Profit Margin | 14.92% |
| EBITDA Margin | 22.24% |
| EBIT Margin | 18.50% |
| FCF Margin | 8.68% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 4.38%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 4.38% |
| Dividend Growth (YoY) | 20.49% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 74.72% |
| Buyback Yield | 1.14% |
| Shareholder Yield | 5.52% |
| Earnings Yield | 7.09% |
| FCF Yield | 4.13% |
Stock Splits
The last stock split was on November 16, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Nov 16, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
CSPCY has an Altman Z-Score of 5.87.
| Altman Z-Score | 5.87 |
| Piotroski F-Score | n/a |